ES2149812T3 - Metodo y composiciones para mejorar el funcionamiento de los leucocitos sobre una superficie mucosa o cutanea. - Google Patents

Metodo y composiciones para mejorar el funcionamiento de los leucocitos sobre una superficie mucosa o cutanea.

Info

Publication number
ES2149812T3
ES2149812T3 ES93908579T ES93908579T ES2149812T3 ES 2149812 T3 ES2149812 T3 ES 2149812T3 ES 93908579 T ES93908579 T ES 93908579T ES 93908579 T ES93908579 T ES 93908579T ES 2149812 T3 ES2149812 T3 ES 2149812T3
Authority
ES
Spain
Prior art keywords
compositions
refers
leukocytes
mucous
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93908579T
Other languages
English (en)
Spanish (es)
Inventor
Michael A Rudy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytologics Inc
Original Assignee
Cytologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytologics Inc filed Critical Cytologics Inc
Application granted granted Critical
Publication of ES2149812T3 publication Critical patent/ES2149812T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES93908579T 1992-03-26 1993-03-25 Metodo y composiciones para mejorar el funcionamiento de los leucocitos sobre una superficie mucosa o cutanea. Expired - Lifetime ES2149812T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/858,290 US5466680A (en) 1992-03-26 1992-03-26 Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface

Publications (1)

Publication Number Publication Date
ES2149812T3 true ES2149812T3 (es) 2000-11-16

Family

ID=25327958

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93908579T Expired - Lifetime ES2149812T3 (es) 1992-03-26 1993-03-25 Metodo y composiciones para mejorar el funcionamiento de los leucocitos sobre una superficie mucosa o cutanea.

Country Status (7)

Country Link
US (1) US5466680A (fr)
EP (1) EP0633767B1 (fr)
JP (1) JPH07509449A (fr)
CA (1) CA2132613C (fr)
DE (1) DE69329022T2 (fr)
ES (1) ES2149812T3 (fr)
WO (1) WO1993018747A1 (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212426B (en) * 1992-07-22 1996-06-28 Vepex Kft Process for producing bioactive pharmaceutical compositions
MY113046A (en) * 1994-03-22 2001-11-30 Astrazeneca Uk Ltd Pharmaceutical compositions
US5681553A (en) * 1994-12-06 1997-10-28 Texturizer, Inc. Method and system for treating damaged hair
FR2732598B1 (fr) 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US6168798B1 (en) * 1997-02-03 2001-01-02 Bristol-Myers Squibb Company Non-irritating composition for treating acne and other skin conditions
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
US6063406A (en) * 1997-04-18 2000-05-16 Chemcraft, Inc. Skin care compositions
US20050112543A1 (en) * 1998-03-11 2005-05-26 The General Hospital Corporation Method of screening for drugs useful in treating Alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US6323218B1 (en) * 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
FR2780650B1 (fr) 1998-07-03 2000-09-08 Goemar Lab Sa Solutions salines, leur procede de preparation et medicaments a base de ces solutions
US7566740B2 (en) * 1998-10-06 2009-07-28 Bml Pharmaceuticals, Inc. Method of treating mucositis
US6669928B1 (en) * 1999-05-13 2003-12-30 Tamer International, Ltd. Periodontal composition
US7018365B2 (en) 1999-05-21 2006-03-28 Micro Therapeutics, Inc. Threaded syringe with quick stop
US6187332B1 (en) * 1999-06-14 2001-02-13 Wisconsin Alumni Research Foundation Acidic buffered nasal spray
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
US8697109B2 (en) 2000-08-16 2014-04-15 Encore Health, Llc Caged mercaptan and seleno-mercaptan compounds and methods of using them
US7914815B2 (en) 2000-08-16 2011-03-29 Encore Health, Llc Method for delivery of pharmaceuticals for treating or preventing presbyopia
US8147816B2 (en) * 2000-08-16 2012-04-03 Encore Health, Llc Presbyopia treatment by lens alteration
US20050112113A1 (en) * 2000-08-16 2005-05-26 Till Jonathan S. Presbyopia treatment by lens alteration
US8647612B2 (en) 2008-03-05 2014-02-11 Encore Health, Llc Dithiol compounds, derivatives, and treatment of presbyopia
US7935332B2 (en) * 2000-08-16 2011-05-03 Encore Health, Llc Presbyopia treatment by lens alteration
MXPA03002092A (es) * 2000-09-08 2004-11-01 Al Siamon Solucion topica terapeutica para la piel y metodo asociado de uso.
FI111732B (fi) * 2000-09-15 2003-09-15 Noviant Oy Ligandimodifioitu selluloosatuote
EP1609468A3 (fr) * 2000-11-22 2006-01-25 Rxkinetix, Inc. Une composition sur la base d'un antioxydant contenant du soufre et son utilisation pour la production d'un médicament pour le traitement de la mucosite
RU2259825C9 (ru) * 2001-06-18 2006-04-10 БиоДием Лимитед Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
US7097860B2 (en) * 2001-08-03 2006-08-29 Aaron Moshenyat Method and composition for treatment of inflammatory and inflammation-related disorders
US20030068297A1 (en) * 2001-08-18 2003-04-10 Deepak Jain Composition and methods for skin rejuvenation and repair
WO2003092654A1 (fr) * 2002-05-02 2003-11-13 President And Fellows Of Harvard College Formulations limitant l'extension d'infections pulmonaires
US6844014B1 (en) 2002-07-22 2005-01-18 Stephen Rafkin Herbal healing lotion for veterinary use
KR20060002768A (ko) * 2003-03-11 2006-01-09 후지필름 일렉트로닉 머티리얼스 유.에스.에이., 아이엔씨. 새로운 감광성 수지 조성물들
US7090882B2 (en) 2003-06-12 2006-08-15 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
US7588696B2 (en) 2003-06-12 2009-09-15 Cargill, Incorporated Antimicrobial water softener salt and solutions
US7658959B2 (en) 2003-06-12 2010-02-09 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
US7883732B2 (en) 2003-06-12 2011-02-08 Cargill, Incorporated Antimicrobial salt solutions for cheese processing applications
IL160936A0 (en) * 2004-02-05 2004-08-31 Scott A Cordray Nasal spray and wash
US20050196434A1 (en) * 2004-03-04 2005-09-08 Brierre Barbara T. Pharmaceutical composition and method for the transdermal delivery of magnesium
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
WO2005117852A1 (fr) * 2004-06-01 2005-12-15 Cameco Corporation Composition pour le traitement d’une brûlure à l’acide fluorhydrique
AU2006247077A1 (en) * 2005-05-18 2006-11-23 Pulmatrix Inc. Formulations for alteration of biophysical properties of mucosal lining
US20090191510A1 (en) * 2005-06-22 2009-07-30 Cao Group, Inc. Periodontal treatment employing applied ultrasonic energy
US7687078B1 (en) * 2005-10-05 2010-03-30 Scott Cordray Method of treatment
US7541052B1 (en) * 2005-12-23 2009-06-02 Scott Cordray Hypertonic solutions and method of treatment
US8486472B2 (en) 2006-01-18 2013-07-16 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
US20070292493A1 (en) * 2006-06-15 2007-12-20 Brierre Barbara T Pharmaceutical composition and method for the transdermal delivery of calcium
US7862538B2 (en) * 2008-02-04 2011-01-04 Incept Llc Surgical delivery system for medical sealant
US9044439B2 (en) * 2008-03-05 2015-06-02 Encore Health, Llc Low dose lipoic and pharmaceutical compositions and methods
WO2009111635A2 (fr) 2008-03-05 2009-09-11 Encore Health, Llc Composés dithiols, dérivés et utilisations associées
ES2759373T3 (es) * 2008-06-12 2020-05-08 Medtronic Xomed Inc Producto para el tratamiento de heridas crónicas con un sistema extracelular de solvatación de sustancias poliméricas
TWI580441B (zh) * 2008-09-19 2017-05-01 愛爾康研究有限公司 穩定的藥學次微米懸浮液及其形成方法
ES2625260T5 (es) 2009-03-26 2020-07-29 Pulmatrix Operating Co Inc Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares
DK2315580T3 (da) * 2009-03-26 2012-04-10 Pulmatrix Inc Farmaceutiske formuleringer og fremgangsmåder til behandling af luftvejsinfektioner
WO2010147962A1 (fr) 2009-06-15 2010-12-23 Encore Health, Llc Esters de choline
EP3069612A3 (fr) 2009-06-15 2016-10-19 Encore Health, LLC Composés dithiols, dérivés et leurs utilisations
CN103200938B (zh) 2010-08-30 2018-07-31 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
WO2012030645A1 (fr) 2010-08-30 2012-03-08 Pulmatrix, Inc. Poudre sèche respirable contenant du lactate de sodium, du chlorure de sodium et de la leucine
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
PT3470057T (pt) 2010-09-29 2021-12-03 Pulmatrix Operating Co Inc Pós secos catiónicos compreendendo sais de magnésio
BR112013007304B1 (pt) 2010-09-29 2021-12-14 Pulmatrix, Inc. Pós secos de cátion de metal monovalente para inalação
JP5788013B2 (ja) * 2010-10-29 2015-09-30 ヒューレット−パッカード デベロップメント カンパニー エル．ピー．Ｈｅｗｌｅｔｔ‐Ｐａｃｋａｒｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏｍｐａｎｙ， Ｌ．Ｐ． 塩化カルシウムを低減した紙強化処理
CN107596518B (zh) 2012-02-29 2021-04-23 普马特里克斯营业公司 可吸入干粉剂
BR112015003074A2 (pt) 2012-08-17 2017-07-04 Intervet Int Bv composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético.
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
CA2941518A1 (fr) 2014-03-03 2015-09-11 Encore Vision, Inc. Compositions d'ester de choline de l'acide lipoique et procedes d'utilisation correspondants
US11207346B2 (en) * 2016-06-07 2021-12-28 Nutreco Nederland B.V. Aqueous composition for livestock animals
WO2020014644A1 (fr) * 2018-07-12 2020-01-16 The Regents Of The University Of Michigan Compositions et procédés pour des formulations contenant du métal pouvant moduler une réponse immunitaire
ES2949880A1 (es) * 2022-02-27 2023-10-03 Vidal Miquel Gonzalez Medicamento natural para el tratamiento de hemorroides y posologia de aplicacion

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2556567A (en) * 1949-04-01 1951-06-12 Tampax Inc Douche composition
JPS6153220A (ja) * 1984-08-22 1986-03-17 Sapporo Breweries Ltd 新規多糖体ｒｏｎ物質，その製造法およびそれを有効成分とする抗腫瘍剤，免疫調節剤並びに感染症予防治療剤
US3337404A (en) * 1965-06-28 1967-08-22 Merck & Co Inc Effervescent potassium composition
US3703438A (en) * 1969-04-08 1972-11-21 Bruss I Perelivania Krovi Method for the stabilization of blood
US3897550A (en) * 1971-06-01 1975-07-29 Cybersol Method for administering water soluble drugs, nutrients and other solutes to a mammal
US3830910A (en) * 1972-03-16 1974-08-20 C Homsy Pseudo-synovial plastic body fluids and method of preparing same
US3809747A (en) * 1972-04-20 1974-05-07 C Toscano Solution for treatment of hair and scalp
US3993751A (en) * 1972-11-27 1976-11-23 Cybersol, Inc. Process for stabilizing therapeutic compositions and article
US3911114A (en) * 1973-01-26 1975-10-07 Arizona Feeds Composition and method for treating stressed ruminants
US3874927A (en) * 1973-08-16 1975-04-01 Caw Ind Inc Method of washing soiled culinary articles
US4048123A (en) * 1973-08-17 1977-09-13 Barnes-Hind Pharmaceuticals, Inc. Abradant skin cleanser
US3899579A (en) * 1974-01-25 1975-08-12 Eric C Anderson Treatment of emphysema, polyarthritis syndrome and pectin related diseases in ruminants
US3935067A (en) * 1974-11-22 1976-01-27 Wyo-Ben Products, Inc. Inorganic support for culture media
US3993750A (en) * 1974-12-20 1976-11-23 Research Corporation Aqueous hypertonic solution and compositions useful for preparation of same
GB1501019A (en) * 1975-04-03 1978-02-15 Borchorst B Shampoo
US4024237A (en) * 1975-08-04 1977-05-17 Bertram Eichel Novel compositions for establishing environmental conditions favorable to oral leucocytes
US4077842A (en) * 1976-03-19 1978-03-07 Cory Robert Paul Stabilized glucose isomerase enzyme concentrate
US4084747A (en) * 1976-03-26 1978-04-18 Howard Alliger Germ killing composition and method
US4276287A (en) * 1976-04-29 1981-06-30 Cabardo Jr Alberto Periodontal powder
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
CA1076479A (fr) * 1976-09-17 1980-04-29 Lewis/Howe Company Suspensions ou emulsions concentrees d'hydroxyde de magnesium, et methode de fabrication
JPS6043324B2 (ja) * 1977-10-20 1985-09-27 ライオン株式会社 口腔用組成物
US4229430A (en) * 1978-08-21 1980-10-21 Fahim Mostafa S Oral composition for improving oral health
US4238482A (en) * 1978-09-29 1980-12-09 Peyman Gholam A Intraocular infusion irrigation solution and method
US4603122A (en) * 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
US4315001A (en) * 1979-08-17 1982-02-09 Blough Herbert A 2-Deoxy glucose as an antiviral agent against herpes simplex
JPS5632411A (en) * 1979-08-27 1981-04-01 Tomita Seiyaku Kk Preparation of perfusion liquid for artificial kidney dialysis
US4489535A (en) * 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS57142907A (en) * 1981-02-27 1982-09-03 Shionogi & Co Ltd Bacterium-originated insecticide and its preparation
HU195618B (en) * 1981-03-17 1988-06-28 Human Oltoanyagtermelo Process for producing composition for treating epidermic lesions of skin
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4447562A (en) * 1981-07-15 1984-05-08 Ivani Edward J Amino-polysaccharides and copolymers thereof for contact lenses and ophthalmic compositions
US4550022A (en) * 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
US4443432A (en) * 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
IT1172185B (it) * 1981-12-21 1987-06-18 Serono Ist Farm Composizione particolarmente per la vande vaginali
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
US4970220A (en) * 1982-05-17 1990-11-13 S. C. Johnson & Son, Inc. Skin conditioning composition
US4582705A (en) * 1982-07-12 1986-04-15 Leonard Primes Composition for detoxification
US4600711A (en) * 1982-08-18 1986-07-15 The University Of Kentucky Research Foundation Composition for topical and infusion treatment of wounds and burns
US4465673A (en) * 1983-01-10 1984-08-14 Yasuo Tanaka Pentagalloylglucose antiviral composition
US4811747A (en) * 1983-03-28 1989-03-14 Reis Virginia H Orange juice hair treatment method
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4552814A (en) * 1984-05-21 1985-11-12 The Dow Chemical Company Advanced epoxy resins having improved impact resistance when cured
FI852105L (fi) * 1984-05-29 1985-11-30 Ciba Geigy Ag Acylerade sockerderivat, foerfarande foer deras framstaellning och deras anvaendning.
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
JPH0742219B2 (ja) * 1984-07-26 1995-05-10 ライオン株式会社 口腔用組成物
US4610874A (en) * 1985-04-12 1986-09-09 Neutrogena Corporation Hair conditioner
US4640911A (en) * 1985-05-29 1987-02-03 Ciba-Geigy Corporation Acylated sugar derivatives, processes for their manufacture, and their use
US4696917A (en) * 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
US4886786A (en) * 1985-08-01 1989-12-12 Lindstrom Richard L Additive for irrigation solution or surgical solution
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate
GB8520664D0 (en) * 1985-08-17 1985-09-25 Euro Celtique Sa Suppository
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4900722A (en) * 1985-08-19 1990-02-13 Bioglucans, L.P. Methods and compositions for prophylactic and therapeutic treatment of infections
US4634591A (en) * 1985-09-06 1987-01-06 Westerman Robert D Anti-gagging compositions and method of treating gagging reflexes
US4670256A (en) * 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
US4952392A (en) * 1986-03-17 1990-08-28 Peri-Oral Dental Products, Inc. Use of periwinkle in oral hygiene
US4725433A (en) * 1986-07-31 1988-02-16 Neutrogena Corporation Novel hair conditioner
JP2930589B2 (ja) * 1986-10-06 1999-08-03 ザ ユニバーシィティ オブ バージニア アルミニ パテンツ ファンデーション 外科手術中における改善された心臓保護のためのアデノシン，ヒポキサンチン及びリボース含有溶液の使用
US4788060A (en) * 1986-10-27 1988-11-29 Abbott Laboratories Multiple electrolyte douche and wipe composition
ES2055685T3 (es) * 1986-11-14 1994-09-01 Puetter Medice Chem Pharm Procedimiento para la obtencion de un medicamento que contiene ibuprofen.
US4886665A (en) * 1987-03-11 1989-12-12 Arcopharma Ltd. Compositions of oats and nettle extracts to be used as a food additive or pharmaceutical preparation in human health care
US4877773A (en) * 1987-04-29 1989-10-31 Turner Leola E B Pharmaceutical preparation
DE3815360A1 (de) * 1988-05-05 1989-11-16 Dibbert Hans Juergen Dr Med Verwendung einer waessrigen glucoseloesung als mittel zur spuelung des nasen- und/oder rachenraumes
US4906460A (en) * 1988-08-05 1990-03-06 Sorenco Additive for hair treatment compositions
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
US5026547A (en) * 1988-11-11 1991-06-25 Meiji Seika Kaisha, Ltd. Compound having insecticidal activity and insecticide composition containing the same
US4906461A (en) * 1988-11-21 1990-03-06 Warren Chambers Hair treatment composition
AU621972B2 (en) * 1988-12-14 1992-03-26 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cell culture medium for human liver epithelial cell line
JPH037236A (ja) * 1989-02-10 1991-01-14 Nippon Chem Res Kk ヘルペスウイルスの吸着阻害剤
JP2681527B2 (ja) * 1990-02-15 1997-11-26 ジャパンファインケミカル株式会社 細胞活性促進外用剤

Also Published As

Publication number Publication date
EP0633767B1 (fr) 2000-07-12
WO1993018747A1 (fr) 1993-09-30
DE69329022T2 (de) 2001-05-17
CA2132613C (fr) 2008-02-19
CA2132613A1 (fr) 1993-09-30
US5466680A (en) 1995-11-14
JPH07509449A (ja) 1995-10-19
DE69329022D1 (de) 2000-08-17
EP0633767A1 (fr) 1995-01-18
EP0633767A4 (fr) 1995-06-07

Similar Documents

Publication Publication Date Title
ES2149812T3 (es) Metodo y composiciones para mejorar el funcionamiento de los leucocitos sobre una superficie mucosa o cutanea.
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
ES2095017T3 (es) Composicion cosmetica o farmaceutica que comprende en asociacion una peroxidasa y un agente antioxigeno singulete.
ES2099977T5 (es) Composiciones de liberacion prolongada para tratar enfermedades periodontales.
MX9703354A (es) Composiciones para tratar el acné y curar heridas que contienen un piruvato, un antioxidante y una mezcla de acidos grasos.
ES2124225T3 (es) Tratamiento de la disfuncion erectil.
PE13197A1 (es) Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas
ES2059965T3 (es) Un procedimiento para preparar una composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
ES2082833T3 (es) Uso de monooleina en el tratamiento de la bolsa periodontal.
PT782448E (pt) Formulacoes oticas antibacterianas nao ototoxicas nao sensibilizantes nao irritantes
BR8803709A (pt) Umectante para uma composicao de tratamento de pele e a respectiva composicao
PT1035844E (pt) Utilizacao de poliois no combate a infeccoes por leveduras e preparacoes de poliol para a referida utilizacao
ES2057791T3 (es) Composicion cosmetica reductora para la deformacion permanente de los cabellos, a base de un ester de acido tioglicolico y de n-acil (c2-c4) cisteamina y su procedimiento de realizacion.
ES2112669T3 (es) Utilizacion de acidos carboxilicos hidroxilados para el tratamiento de las u¦as
AR045748A1 (es) Metodo para alargar el cabello con composiciones que comprenden un alfa-hidroxiacido y un agente de reduccion
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
ES2182255T3 (es) Agente de blanqueo fluorescente.
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
ITMI981586A0 (it) Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
ES2092918T3 (es) Procedimiento para la deformacion permanente de materias queratinicas.
ES2124983T5 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
ATE215810T1 (de) Abschuppungs-zusammensetzung
EP1037918A4 (fr) Procede et composition pour ameliorer l'efficacite d'un vaccin
MX9304185A (es) Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 633767

Country of ref document: ES